In His Blood
September 9, 2019
Hemophilia hasn’t slowed down 3-year-old Braxton—thanks to doctors from CHLA
Content related to For Kids with Hemophilia, New Protein Extends Time Between Infusions
Preventing and Recognizing Blood Clots
December 6, 2019
Everything parents should know about spotting and preventing blood clots in children
Big Relief in a Small Pack
July 12, 2022
The Hematology-Adolescent Medicine Clinic at Children’s Hospital Los Angeles cares for patients with a variety of bleeding disorders, including heavy periods. For those experiencing period poverty
Cisplatin and Hearing Loss: Until Now, an Unquantified Risk
February 12, 2021
Children’s Hospital Los Angeles leads largest ever multi-center study to characterize side effects of a common chemotherapy agent
Treatment Significantly Reduces Chemotherapy-Induced Hearing Loss in Children
December 6, 2016
Investigators from Children’s Hospital Los Angeles and 37 other Children’s Oncology Group hospitals in the U.S. and Canada have determined that sodium thiosulfate prevents cisplatin-induced hearing
Genetic Clotting Disorder in Children
October 9, 2015
A blood clot is when blood changes from a liquid to a solid. Some kids are born with a genetic condition that makes them at greater risk for a blood clot.
Management of Sickle Cell Disease: A Perspective for Pediatricians
March 3, 2020
Sickle cell disease (SCD) is one of the most common genetic blood disorders, affecting over 100,000 Americans and 1 in 365 African-American newborn babies. It is an autosomal recessive condition
Chemotherapy and Hearing Loss: Until Now, an Unquantified Risk
October 25, 2020
Researchers at Children’s Hospital Los Angeles led a multi-institutional study that pins down, for the first time, the actual risk of hearing loss from cisplatin, a common chemotherapy agent
![10E4_CHLA90_2[2] (tumor-associated macrophages)](/sites/default/files/styles/16x9_half/public/thumbnails/image/10E4_CHLA90_2%5B2%5D%20%281%29.jpg.webp?itok=mArbKB0V)
Removing the Enablers: Reducing the number of tumor-supporting cells to fight neuroblastoma
May 16, 2018
Investigators at the Children’s Center for Cancer and Blood Diseases at Children’s Hospital Los Angeles provide preclinical evidence that the presence of tumor-associated macrophages—a type of immune